These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 30672115)

  • 1. Donor mucosal immunocytes perpetuate refractory GVHD after intestinal transplantation without engrafting in recipient bone marrow: Case report and review of the literature.
    Stanley K; Ranganathan S; Mazariegos G; Bond G; Soltys K; Ganoza A; Jones K; Cieply K; Sindhi R
    Pediatr Transplant; 2019 Mar; 23(2):e13350. PubMed ID: 30672115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphohematopoietic graft-versus-host responses promote mixed chimerism in patients receiving intestinal transplantation.
    Fu J; Zuber J; Shonts B; Obradovic A; Wang Z; Frangaj K; Meng W; Rosenfeld AM; Waffarn EE; Liou P; Lau SP; Savage TM; Yang S; Rogers K; Danzl NM; Ravella S; Satwani P; Iuga A; Ho SH; Griesemer A; Shen Y; Prak ETL; Martinez M; Kato T; Sykes M
    J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33630757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I diagnose and treat acute graft-versus-host disease after solid organ transplantation.
    Cooper JP; Abkowitz JL
    Blood; 2023 Mar; 141(10):1136-1146. PubMed ID: 36395067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of peripheral blood chimerism in graft-vs-host disease following orthotopic liver transplantation: case report and review of the literature.
    Schulman JM; Yoon C; Schwarz J; Vagefi PA; Mully TW; Shinkai K
    Int J Dermatol; 2014 Nov; 53(11):e492-8. PubMed ID: 24372059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of acute and chronic graft-versus-host disease and donor T-cell chimerism after small bowel or combined organ transplantation.
    Shin CR; Nathan J; Alonso M; Yazigi N; Kocoshis S; Tiao G; Davies SM
    J Pediatr Surg; 2011 Sep; 46(9):1732-8. PubMed ID: 21929982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graft-versus-host Disease After Intestinal or Multivisceral Transplantation: A Scandinavian Single-center Experience.
    Cromvik J; Varkey J; Herlenius G; Johansson JE; Wennerås C
    Transplant Proc; 2016; 48(1):185-90. PubMed ID: 26915866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic establishment and maintenance of the human intestinal B cell population and repertoire following transplantation in a pediatric-dominated cohort.
    Fu J; Hsiao T; Waffarn E; Meng W; Long KD; Frangaj K; Jones R; Gorur A; Shtewe A; Li M; Muntnich CB; Rogers K; Jiao W; Velasco M; Matsumoto R; Kubota M; Wells S; Danzl N; Ravella S; Iuga A; Vasilescu ER; Griesemer A; Weiner J; Farber DL; Luning Prak ET; Martinez M; Kato T; Hershberg U; Sykes M
    Front Immunol; 2024; 15():1375486. PubMed ID: 39007142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
    Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
    Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
    Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graft-versus-host disease after liver transplantation.
    Taylor AL; Gibbs P; Sudhindran S; Key T; Goodman RS; Morgan CH; Watson CJ; Delriviere L; Alexander GJ; Jamieson NV; Bradley JA; Taylor CJ
    Transplantation; 2004 Feb; 77(3):441-6. PubMed ID: 14966423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graft-versus-host disease after pediatric liver transplantation: A diagnostic challenge.
    Attas RAA; Bader RM; Mashhour M; AlQahtani ZA; Mohammed A; Qahtani M; Arain ZB; Faraidy N; Awaji M; Mohammed G; Alharbi HA; AlZahrani M; Aqool A; Salim G
    Pediatr Transplant; 2022 May; 26(3):e14205. PubMed ID: 34931754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Intestinal Allografts Contain Functional Hematopoietic Stem and Progenitor Cells that Are Maintained by a Circulating Pool.
    Fu J; Zuber J; Martinez M; Shonts B; Obradovic A; Wang H; Lau SP; Xia A; Waffarn EE; Frangaj K; Savage TM; Simpson MT; Yang S; Guo XV; Miron M; Senda T; Rogers K; Rahman A; Ho SH; Shen Y; Griesemer A; Farber DL; Kato T; Sykes M
    Cell Stem Cell; 2019 Feb; 24(2):227-239.e8. PubMed ID: 30503142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe, late-onset graft-versus-host disease in a liver transplant recipient documented by chimerism analysis.
    Pollack MS; Speeg KV; Callander NS; Freytes CO; Espinoza AA; Esterl RM; Abrahamian GA; Washburn WK; Halff GA
    Hum Immunol; 2005 Jan; 66(1):28-31. PubMed ID: 15620459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
    Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of anergic histoincompatible bone marrow allografts.
    Guinan EC; Boussiotis VA; Neuberg D; Brennan LL; Hirano N; Nadler LM; Gribben JG
    N Engl J Med; 1999 Jun; 340(22):1704-14. PubMed ID: 10352162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
    Mawad R; Hsieh A; Damon L
    Transplant Proc; 2009 Dec; 41(10):4431-3. PubMed ID: 20005417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Graft-facilitating doses of ex vivo activated gammadelta T cells do not cause lethal murine graft-vs.-host disease.
    Drobyski WR; Majewski D; Hanson G
    Biol Blood Marrow Transplant; 1999; 5(4):222-30. PubMed ID: 10465102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.